Free Trial

Inhibitor Therapeutics (INTI) SEC Filings & 10K Form

Inhibitor Therapeutics logo
$0.06 +0.01 (+21.38%)
As of 12:14 PM Eastern

Recent Inhibitor Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2025
12:30 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Vasisht Niraj (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:21 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Jerman Michael Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:22 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
OSMAN RONALD E (Reporting)
Ronald E Osman Irrevocable Trust III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:23 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
SEARS SAMUEL P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:25 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
8:28 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
MCNULTY JAMES A (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/19/2025
8:27 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Yanez Michelle (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
11/12/2024
5:27 AM
Inhibitor Therapeutics, Inc. (Filer)
Inhibitor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
8:30 AM
Inhibitor Therapeutics, Inc. (Filer)
Inhibitor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/16/2024
12:34 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Jerman Michael Allen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
OSMAN RONALD E (Reporting)
Ronald E Osman Irrevocable Trust III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
SEARS SAMUEL P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
MCNULTY JAMES A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
12:34 PM
Inhibitor Therapeutics, Inc. (Issuer)
Inhibitor Therapeutics (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
8:00 AM
Inhibitor Therapeutics, Inc. (Filer)
Inhibitor Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:INTI) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners